234 related articles for article (PubMed ID: 33785040)
21. HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia.
Shire NJ; Horn PS; Rouster SD; Stanford S; Eyster ME; Sherman KE;
Hepatology; 2006 Nov; 44(5):1146-57. PubMed ID: 17058240
[TBL] [Abstract][Full Text] [Related]
22. Expression of inhibitory markers is increased on effector memory T cells during hepatitis C virus/HIV coinfection as compared to hepatitis C virus or HIV monoinfection.
Saha B; Choudhary MC; Sarin SK
AIDS; 2013 Sep; 27(14):2191-200. PubMed ID: 23820090
[TBL] [Abstract][Full Text] [Related]
23. Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and Ribavirin.
Petersen T; Lee YJ; Osinusi A; Amorosa VK; Wang C; Kang M; Matining R; Zhang X; Dou D; Umbleja T; Kottilil S; Peters MG
AIDS Res Hum Retroviruses; 2016 Jul; 32(7):660-7. PubMed ID: 26974581
[TBL] [Abstract][Full Text] [Related]
24. Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin.
Monje-Agudo P; Castro-Iglesias A; Rivero-Juárez A; Martínez-Marcos F; Ortega-González E; Real LM; Pernas B; Merchante N; Cid P; Macías J; Merino MD; Rivero A; Mena A; Neukam K; Pineda JA;
Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):1929-36. PubMed ID: 26155784
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected.
Cairoli V; Valle-Millares D; Terrón-Orellano MC; Luque D; Ryan P; Dominguez L; Martín-Carbonero L; De Los Santos I; De Matteo E; Ameigeiras B; Briz V; Casciato P; Preciado MV; Valva P; Fernández-Rodríguez A
J Mol Med (Berl); 2023 Nov; 101(11):1409-1420. PubMed ID: 37704856
[TBL] [Abstract][Full Text] [Related]
26. Impact of HIV infection in patients infected with chronic HCV (genotypes 1a and 3a): virological and clinical changes.
Behzadpour D; Ahmadi Vasmehjani A; Mousavi Nasab SD; Ahmadi NA; Baharlou R
Pathog Glob Health; 2016; 110(7-8):310-315. PubMed ID: 27830997
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the Hepatitis C Continua of Care Between Hepatitis C Virus/HIV Coinfected and Hepatitis C Virus Mono-Infected Patients in Two Treatment Eras During 2008-2015.
Roberson JL; Lagasca AM; Kan VL
AIDS Res Hum Retroviruses; 2018 Feb; 34(2):148-155. PubMed ID: 28974107
[TBL] [Abstract][Full Text] [Related]
28. Cellular activation and intracellular HCV load in peripheral blood monocytes isolated from HCV monoinfected and HIV-HCV coinfected patients.
Dichamp I; Abbas W; Kumar A; Di Martino V; Herbein G
PLoS One; 2014; 9(5):e96907. PubMed ID: 24809719
[TBL] [Abstract][Full Text] [Related]
29. Gene expression profiles in hepatitis C virus (HCV) and HIV coinfection: class prediction analyses before treatment predict the outcome of anti-HCV therapy among HIV-coinfected persons.
Lempicki RA; Polis MA; Yang J; McLaughlin M; Koratich C; Huang DW; Fullmer B; Wu L; Rehm CA; Masur H; Lane HC; Sherman KE; Fauci AS; Kottilil S
J Infect Dis; 2006 Apr; 193(8):1172-7. PubMed ID: 16544259
[TBL] [Abstract][Full Text] [Related]
30. PBMCs gene expression signature of advanced cirrhosis with high risk for clinically significant portal hypertension in HIV/HCV coinfected patients: A cross-control study.
Salgüero S; Brochado-Kith Ó; Verdices AV; Berenguer J; González-García J; Martínez I; Díez C; Hontañón V; Pérez-Latorre L; Fernández-Rodríguez A; Jiménez-Sousa MÁ; Resino S
Biomed Pharmacother; 2023 Mar; 159():114220. PubMed ID: 36628818
[TBL] [Abstract][Full Text] [Related]
31. HIV infection does not increase the risk of liver complications in hepatitis C virus-infected patient with advanced fibrosis, after sustained virological response with direct-acting antivirals.
Corma-Gómez A; Morano L; Téllez F; Rivero-Juárez A; Real LM; Alados JC; Ríos-Villegas MJ; Vera-Méndez FJ; Muñoz RP; Geijo P; Macías J; Pineda JA;
AIDS; 2019 Jun; 33(7):1167-1174. PubMed ID: 30845068
[TBL] [Abstract][Full Text] [Related]
32. HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.
Papasavvas E; Azzoni L; Yin X; Liu Q; Joseph J; Mackiewicz A; Ross B; Lynn KM; Jacobson JM; Mounzer K; Kostman JR; Montaner LJ
J Viral Hepat; 2017 Oct; 24(10):865-876. PubMed ID: 28419653
[TBL] [Abstract][Full Text] [Related]
33. Real-World Clinical Efficacy and Tolerability of Direct-Acting Antivirals in Hepatitis C Monoinfection Compared to Hepatitis C/Human Immunodeficiency Virus Coinfection in a Community Care Setting.
Gayam V; Hossain MR; Khalid M; Chakaraborty S; Mukhtar O; Dahal S; Mandal AK; Gill A; Garlapati P; Ramakrishnaiah S; Mowyad K; Sherigar J; Mansour M; Mohanty S
Gut Liver; 2018 Nov; 12(6):694-703. PubMed ID: 29938459
[TBL] [Abstract][Full Text] [Related]
34. Treatment of chronic HCV genotype 1 coinfection.
Boesecke C; Rockstroh JK
Curr HIV/AIDS Rep; 2015 Sep; 12(3):326-35. PubMed ID: 26228050
[TBL] [Abstract][Full Text] [Related]
35. Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration.
Townsend K; Meissner EG; Sidharthan S; Sampson M; Remaley AT; Tang L; Kohli A; Osinusi A; Masur H; Kottilil S
AIDS Res Hum Retroviruses; 2016 May; 32(5):456-62. PubMed ID: 26559180
[TBL] [Abstract][Full Text] [Related]
36. Higher Activation in CD4(+) T Cells But Similar Viral Control Among HIV/Hepatitis C Virus-Coinfected Patients on a Simplification Monotherapy.
BenMarzouk-Hidalgo OJ; Torres-Cornejo A; Gutierrez-Valencia A; Ruiz-Valderas R; Viciana P; López-Cortés LF
AIDS Res Hum Retroviruses; 2016 Jan; 32(1):6-11. PubMed ID: 26414169
[TBL] [Abstract][Full Text] [Related]
37. A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
Braun DL; Rauch A; Aouri M; Durisch N; Eberhard N; Anagnostopoulos A; Ledergerber B; Müllhaupt B; Metzner KJ; Decosterd L; Böni J; Weber R; Fehr J;
PLoS One; 2015; 10(7):e0133028. PubMed ID: 26176696
[TBL] [Abstract][Full Text] [Related]
38. Mild profile improvement of immune biomarkers in HIV/HCV-coinfected patients who removed hepatitis C after HCV treatment: A prospective study.
Garcia-Broncano P; Medrano LM; Berenguer J; Brochado-Kith O; González-García J; Jiménez-Sousa MÁ; Quereda C; Sanz J; Téllez MJ; Díaz L; JIménez JL; Resino S;
J Infect; 2020 Jan; 80(1):99-110. PubMed ID: 31585189
[TBL] [Abstract][Full Text] [Related]
39. Infection by HTLV-1 Is Associated With High Levels of Proinflammatory Cytokines in HIV-HCV-Coinfected Patients.
Brites C; Abrahão M; Bozza P; Netto EM; Lyra A; Bahia F
J Acquir Immune Defic Syndr; 2018 Feb; 77(2):230-234. PubMed ID: 29084047
[TBL] [Abstract][Full Text] [Related]
40. Responder Interferon λ Genotypes Are Associated With Higher Risk of Liver Fibrosis in HIV-Hepatitis C Virus Coinfection.
Moqueet N; Cooper C; Gill J; Hull M; Platt RW; Klein MB;
J Infect Dis; 2016 Jul; 214(1):80-6. PubMed ID: 26984148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
